Not a member? Sign up for free!

Cognitive Functioning & Neuroprotection In Schizophrenia

Webinar | June 26, 2019 12:00 pm to 1:30 pm ET
You must be logged in to register for PsychU events.

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

Description

Webinar: Cognitive Functioning & Neuroprotection In Schizophrenia

Location: Online Via PsychU.org

Description: Schizophrenia has a worldwide prevalence of approximately 1%.1 Individuals living with the disease often experience neurocognitive deficits, as well as poor memory and attention, which are considered core symptoms for the illness.2 Current evidence also suggests that neuroinflammation, a byproduct of neurotransmitter dysfunctions as a result of increased pro-inflammatory cytokines, may play a role in cognitive dysfunction and neurodegeneration in serious mental illnesses, such as schizophrenia.1

Recent evidence suggests that cognitive deficits may be present even before the onset of illness, making them targets for potential early intervention.2 Neuroprotective strategies that aim to address these factors exist. However, these treatments have limitations.

In this webinar, hear from Dr. René Kahn and Dr. Christoph Correll, as they discuss the trajectory of cognition in the course of illness for schizophrenia and describe potential strategies for measuring cognition. Speakers will also explore the evidence surrounding impacts to patient functioning and address the benefits and risks of a variety of potential neuroprotective strategies.

Speakers are paid consultants to Otsuka Pharmaceutical Development & Commercialization, Inc.

1Aricioglu, F., et. al. (2016) Neuroinflammation in schizophrenia: A critical review and the future. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 26(4), pp. 429-437. Retrieved from https://doi.org/10.5455/bcp.20161123044657. 2Pedersen, T. (2018). Cognitive dysfunction often first sign of schizophrenia. Psych Central. Retrieved from https://psychcentral.com/news/2016/11/03/cognitive-dysfunction-often-first-sign-of-schizophrenia/112018.html.

View Flyer (PDF)

Event Speakers

Christoph Correll, MD
Featured Speaker

Christoph Correll, M.D., is a Professor of Psychiatry at Hofstra Northwell School of Medicine in New York, NY. He also serves as the Medical Director of the Recognition & Prevention (RAP) Program at the Zucker Hillside Hospital. Dr. Correll completed his medical studies at the Free University of Berlin in Germany, and the Dundee University Medical School in Scotland. He completed both a general psychiatry residency and a child and adolescent psychiatry fellowship at Zucker Hillside Hospital.

René Kahn, MD, PhD
Featured Speaker

René Kahn, M.D., Ph.D., is the Esther & Joseph Klingenstein Professor and System Chair of Psychiatry at the Icahn School of Medicine at Mount Sinai. Dr. Kahn is an Honorary Lifetime Professor at Jilin University, as well as a Fellow of the American College of Neuropsychopharmacology. In 2015 and 2016, he was named as a Thomson Reuters’ Highly Cited Researcher. Dr. Kahn completed his medical studies in the Netherlands and was trained as a psychiatrist and neurologist in Utrecht and Amsterdam. He completed a research fellowship in biological psychiatry at Albert Einstein College of Medicine, and a psychiatry residency at Mount Sinai Hospital.

Jehan Marino, PharmD, BCPP
Moderator

Jehan Marino, PharmD, BCPP, is a Senior Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc.

The registration for this event is now closed. For more information about our live event registration process, please read the Live Event Eligibility Requirements